Xcell Therapeutics Inc.

₩954.00As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:373110Healthcare
Country South Korea
PE (Fwd) •••
TSR 2Y CAGR (53.22%)
Div yield —
ROE (271.41%)
Biotechnology
Beta (5Y) 1.11
PE TTM —
TSR TTM (56.93%)
Mkt cap ₩16.50B
ROIC (72.75%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩1,046
9.59%
(74.62%)
Hold 12|6|2|2|8
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
16.73
17.07
18.35
19.21
38.66%
28.32%
35.63%
28.00%
Revenue₩M
851.7
901.1
914.7
920.6
(0.61%)
8.18%
4.60%
5.15%
Peers (US$12.16M)
Cap (US$)
PE
33.87M
—
23.93M
—
12.11M
—
Capital
TTM
5Y
10Y
Leveragex
1.573
(0.045)
(0.037)
EBIT/Intx
2.221
0.241
0.206
Own earn%
(38.89)
151.02
152.76
Sh yield%
44.76
55.01
52.92
Owners
Insiders/Inst%
2.76
41.60
Short interest%
5.96
SBC / revenue%
1.92
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
19–29
$1 testx
—
Incr. ROIC%
16